Jane Street’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-64,228
Closed -$586K 11629
2026
Q1
$586K Sell
64,228
-205,024
-76% -$1.72M ﹤0.01% 7681
2025
Q4
$2M Sell
269,252
-5,659
-2% -$40.7K ﹤0.01% 4805
2025
Q3
$1.84M Buy
+274,911
New +$1.91M ﹤0.01% 5094
2024
Q4
Sell
-40,037
Closed -$478K 9450
2024
Q3
$478K Buy
40,037
+29,726
+288% +$257K ﹤0.01% 7265
2024
Q2
$59.3K Sell
10,311
-374,564
-97% -$2.05M ﹤0.01% 8880
2024
Q1
$2M Buy
384,875
+229,225
+147% +$1.12M ﹤0.01% 4124
2023
Q4
$820K Buy
155,650
+124,401
+398% +$492K ﹤0.01% 5917
2023
Q3
$103K Buy
31,249
+5,626
+22% +$19.7K ﹤0.01% 7942
2023
Q2
$74K Buy
+25,623
New +$49.2K ﹤0.01% 8111
2022
Q2
Sell
-25,152
Closed -$355K 9704
2022
Q1
$355K Buy
+25,152
New +$337K ﹤0.01% 8108

Other funds holding BVS

Jane Street's BVS Position: Q2 2026 in Review

Jane Street sold out of Bioventus (BVS) in Q2 2026, closing a stake of 64,228 shares — an estimated $586K sold.

Jane Street first reported a position in BVS in Q1 2022 and held it in 10 quarters. The position peaked at $2M in Q4 2025. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Jane Street reported no remaining Bioventus position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 64,228 Bioventus shares in Q2 2026, an estimated $586K.
  • Jane Street first reported a position in Bioventus in Q1 2022 and held it in 10 quarters.
  • Jane Street's Bioventus position peaked at $2M in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.